Raynovent Biotech Co. Ltd. has raised ¥370 million (US$54 million) in a series C round to further develop candidates in the field of respiratory and metabolic diseases.

Med-tech firms raising money in public or private financings, including: Holmusk, Medix Infusion, Telesair, Veradigm.

Biopharmas in Asia-Pacific raising money in public or private financings: Actimed, Hightide, Sihuan.

Biopharmas raising money in public or private financings, including: Aeon, Helsinn, Jaguar, Magdalena, Linkinvax, Palisade, Recode.

Baili Biopharmaceutical Co. Ltd. has raised ¥990.47 million (US$146 million) on the Shanghai STAR Market. Its shares opened Jan. 6 at ¥28.75 apiece, surging over 30% its first trading day, and closing at ¥38.40 on Jan.9.

Med-tech firms raising money in public or private financings, including: Evosep Biosystems, Medx Health, Sonivie.

Biopharmas raising money in public or private financings, including: Amolyt, Exevir, Immune-Onc, Spiral.

Skynor Medical (Shanghai) Co. Ltd. has raised ¥100 million (US$15 million) in a financing round to step up its efforts in product development and market expansion. More specifically, the Shanghai-based company intends to use the funds to develop its interventional treatment solutions for neuro and peripheral vascular diseases, as well as expand them to markets at home and abroad.